Clinical Trials · NCT07497503
A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Syneos Health
- Enrollment
- 48
- Start date
- Apr 2026
- Locations
- 1 site, Australia
- Primary endpoint
- Maximum Plasma Concentration (Cmax) of B-3E07